mHealth integration in China

mHealth integration in China

Over the past years, the number of mobile phone subscribers in China has been increasing at an exponential rate. By the end of 2015, there was approximately 202.47 million cell phones produced in China1 along with 1,033.6 million mobile users registered in China, with the number of users expected to grow to 1,086.8 by 2019. […]

了解更多

2016年11月25日

South Korea: Clinical trial opportunities and advantages

Over the last 10 years, South Korea has increasingly become a global clinical trial (CT) hub and has established itself as one of the leading CT destinations in the Asia region. In 2015, South […]

了解更多

2016年11月19日

Expanding Data Management Services in China

EDC has become the data management platform of choice around the world, offering advantages such as increasing the quality and timely collection of data. Medrio, an EDC company that offers eClinical software solutions, has quoted that 70% of clinical trials are using EDC as a forms of collecting data in the United States. In China, […]

了解更多

2016年11月7日

Record-setting metrics for Chinese Phase III Diabetes Study

Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations.  One such example of 乔治临 […]

了解更多

2016年10月20日

乔治临床( George Clinical ) welcomes Cardio Union and The George Institute for Global Health’s establishment of the Heart Health Research Center

BEIJING – October 15, 2016 – 乔治临床( George Clinical ) welcomes the establishment of the Heart Health Research Center, a collaborative initiative developed by Cardio Union, an emerging multi-dis […]

了解更多

2016年10月18日

乔治临床( George Clinical ) welcomes the INVICTUS program

乔治临床( George Clinical ) welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The […]

了解更多

2016年6月14日

China’s Future in Global Clinical Research

Philip Gregory of George Clinical focuses on China, in a three part series originally published on http://innovations.bbkworldwide.com/part-iii-chinas-future-in-global-clinical-research that d […]

了解更多

2016年1月19日

China State Council’s new directive herald key changes for Chinese R&D

In a surprise move, the State Council in China has recently released a directive announcing its view on reforming the drug and medical device review and approval process in China. The State Co […]

了解更多

2015年9月1日

乔治临床( George Clinical ) In China Celebrates Two Years As An Independent CRO

乔治临床( George Clinical ) in China recently celebrated its second anniversary as an independent entity in China. Although 乔治临床( George Clinical ) has been conducting Phase 11 to Phase IV studies […]

了解更多

2015年8月26日

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )